课题基金 / 基金详情

The Role of Nanog in Establishment and Patterning of Embryonic Pluripotency

The Role of Nanog in Establishment and Patterning of Embryonic Pluripotency
Nanog 在胚胎多能性建立和模式化中的作用
批准号:
MR/L001047/1
负责人:
Andrew Johnson
金额:
$64.15万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Andrew Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Embryonic stem (ES) cells can become any cell in the body, and so they have great potential as a tool for regenerative medicine to repair tissue damaged by injury or disease. A major goal of modern medicine, therefore, is to understand how to harvest the potential of embryonic stem cells for therapeutic purposes. The signature ability of ES cells to become other cells is called pluripotency, which is carefully regulated by protein factors, called pluripotency factors, which control the genes that regulate ES cell behaviour. We are working to identify how those genes are controlled, and we have focused on one of the most important pluripotency factors, called Nanog, a master regulator of stem cell behaviour.ES cells resemble the cells that make up early embryos, and so by understanding how embryos develop it becomes it is possible to learn how to regulate ES cells to make specific types of adult cells. However, to understand how ES cells become pluripotent, it is necessary to consider the establishment of pluripotency in the embryo itself. However, the embryos of humans, and other mammals, are very small, and they develop inside the mother, so they are very difficult to access and to manipulate. A way around this problem is use the embryos of other species, whose cells resemble those of human embryos, but which are much easier to work with. This approach has been used for decades in biology to identify the function of genes in embryonic cells. However, we discovered that the embryos of frogs and fish, which most investigators use in the lab, do not contain pluripotent cells. For this reason we had to develop a novel experimental system using embryos from axolotls.Mammals evolved from amphibians, of which there are two types, frogs and salamanders. These two types of amphibians last had a common relative 250 million years ago. Since then, frogs have evolved many traits are unique to them, however salamanders have remained relatively unchanged since they first walked the earth, and they evolved into reptiles and mammals. For this reason, the genes that control the development of embryos from salamanders and mammals are almost the same. In fact, axolotls are representative salamanders, and we have shown that they contain pluripotent cells that are basically the same as the ones that develop in human embryos. Also, importantly, they contain a Nanog gene, which for reasons that are not entirely clear, does not exist in frog embryos. For our purposes axolotl embryos are a perfect tool to understand how pluripotent cells respond to signals that tell them to become other cell types. We are using axolotl embryos to study how Nanog is regulated.Axolotl embryos develop outside of the mother, so hundreds of embryos can be collected without harming the animals. Also, the embryos are enormous, about 10,000 times the size of human embryos, so it is very easy to dissect the cells you want to study in the lab. The axolotl experimental system that we developed is unique in the UK, and we are the only group in the world currently using it to understand pluripotency. When we isolated the Nanog gene from axolotls we showed that it works as well as human Nanog in controlling the behaviour of ES cells. But ES cells are not embryos, and we have the unique opportunity to understand how Nanog functions in a normal embryo, the embryo of an axolotl.In this project we will take the pluripotent cells in axolotl embryos and induce them to become specific types of differentiated cells using solutions that contain the molecules that control development of normal embryos. We will then analyse how the loss of Nanog changes the response to these signals. By identifying how the cells respond we will understand the necessary first step in the establishment of pluripotency, and this will provide cues for how to produce human tissue for regenerating damaged body parts.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s42003-021-02217-8
发表时间: 2021-06-07
期刊: Communications biology
影响因子: 5.9
作者: [Blythe MJ, Kocer A, Rubio-Roldan A, Giles T, Abakir A, Ialy-Radio C, Wheldon LM, Bereshchenko O, Bruscoli S, Kondrashov A, Drevet JR, Emes RD, Johnson AD, McCarrey JR, Gackowski D, Olinski R, Cocquet J, Garcia-Perez JL, Ruzov A]
通讯作者: Ruzov A
DOI: 10.1186/s13148-015-0117-x
发表时间: 2015
期刊: Clinical epigenetics
影响因子: 5.7
作者: [Eleftheriou M, Pascual AJ, Wheldon LM, Perry C, Abakir A, Arora A, Johnson AD, Auer DT, Ellis IO, Madhusudan S, Ruzov A]
通讯作者: Ruzov A
DOI: 10.1242/dev.105346
发表时间: 2014-06
期刊: Development (Cambridge, England)
影响因子: --
作者: [Chatfield J, O'Reilly MA, Bachvarova RF, Ferjentsik Z, Redwood C, Walmsley M, Patient R, Loose M, Johnson AD]
通讯作者: Johnson AD
DOI: 10.1242/dev.113993
发表时间: 2015-08-15
期刊: Development (Cambridge, England)
影响因子: --
作者: [Johnson AD, Alberio R]
通讯作者: Alberio R
ARTS: A corevision of the pinhole borers (Coleoptera: Curculionidae: Platypodinae) and symbiotic fungi (Raffaelea spp.) via multi-generational systematics training
  • 批准号:
    2342481
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $120.0万
  • 财政年份:
    2024
  • 负责人:
    Andrew Johnson
  • 依托单位:
Research Infrastructure: MRI: Track 2 Acquisition of Data Observation and Computation Collaboratory (DOCC)
  • 批准号:
    2320261
  • 项目类别:
    Standard Grant
  • 资助金额:
    $154.85万
  • 财政年份:
    2023
  • 负责人:
    Andrew Johnson
  • 依托单位:
Innovative Material, Processes and Devices for Low Power Flexible Electronics: Creating a Sustainable Internet of Everything
  • 批准号:
    EP/X025195/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $296.12万
  • 财政年份:
    2023
  • 负责人:
    Andrew Johnson
  • 依托单位:
Collaborative Research: Cross-Cutting Improvements: FAIR Facilities and Instruments: Enabling transparency, reproducibility, and equity through persistent identifiers
  • 批准号:
    2226397
  • 项目类别:
    Standard Grant
  • 资助金额:
    $12.52万
  • 财政年份:
    2022
  • 负责人:
    Andrew Johnson
  • 依托单位:
国内基金
海外基金
核心钟基因BMAL1介导SMAD2/3共转录调 控多能基因NANOG的m6A修饰在胚胎干细 胞早期分化中的作用和机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    蔡炳
  • 依托单位:
Nanog-HDAC6调控轴促进卵巢癌免疫治疗抵抗的分子机制研究
  • 批准号:
    82360595
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    邓青春
  • 依托单位:
LncRNA TILA通过正反馈环路促进TAZ/NANOG液相分离维持乳腺癌干细胞特性的机制研究
  • 批准号:
    82373341
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    刘馨蔚
  • 依托单位:
NANOG在猪早期胚胎和多能性干细胞中物种特异性转录表达模式与功能机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    刘忠华
  • 依托单位: